About the Event

Join us for an exciting conference on Point of Care Diagnostics (POCD) and the latest trends and innovations in Point of Care Testing (POCT) and diagnostic technologies. POCT has gained significant traction worldwide, with an increasing demand for it, leading to a shift of care from hospitals to communities. Novel diagnostic technologies have the potential to reduce costs and improve speed, quality and access, so patients in remote or resource-limited areas can receive reliable diagnostic tests.

While cures for viral diseases such as COVID-19 are challenging, detection and surveillance are key to reducing their spread. The rapid spread of COVID-19 test kits in the community has demonstrated the potential and impressive scalability of rapid POCT diagnostics. The range of applications is vast and varied and at this event, we will discuss barriers and opportunities for POCT in our ecosystem as well as challenges such as traceability, accountability, accuracy and risks in test conduction.

This full-day event will feature a broad range of topics: how to bring products to market, market trends and opportunities, manufacturing capabilities, emerging wearables and other innovations, product development programs, commercial success and de-risking the pathway to market.

We will also explore the impact of CRISPR on PCR and other POCT products, connectivity, cyber security, data and the implications for patients and healthcare.

Don’t miss this opportunity to learn about the latest developments in POCT and the future of diagnostic technologies.

Join us and be informed!

Who should attend?

This is a must-attend event for:

• Diagnostic technology companies and research institutes developing products for the local or global market
• POCD/POCT professionals seeking to improve knowledge, awareness and expertise
• Medtech professionals looking to diversify product offering into the POCD/POCT space

We strongly recommend those in the following fields to participate:

• Research and development, science and academia, manufacturing, industry service provision, consultancy, regulatory, government

We welcome all:

• Founders, CEOs, CSOs, CTOs, commercial heads, BD managers, product developers, product designers, engineers, researchers, scientists.

Featuring speakers from:

• Australian Medtech Manufacturing Centre (AMMC)
• CSIRO
• FB Rice
• Honan
• IQVIA MedTech
• Lumos Diagnostics
• M3DICINE
• Melbourne Centre for Nanofabrication
• Monash University
• MTPConnect
• Pathology Technology Australia
• ProtonIntel
• Radium Capital
• Roche Diagnostics Australia Pty Limited
• SCHOTT MINIFAB
• The Peter Doherty Institute for Infection and Immunity

Event details:

Date: Thursday 27 April 2023
Time (AEST):
8:15am – Registration, tea, coffee and networking
8:45am – 5:30pm – Session 1 – 4
5:30pm – 6:30pm – Networking
Format: In-person only
Venue: International Chamber House, Theatrette, Level 5, 121 Exhibition Street, Melbourne 3000
Host: Jeff Malone, CEO, BioMelbourne Network

Early-bird registration (Closing soon):

Member: $370
Non-Member: $660

Cancellation Policy

In-person registration:

• Full refund given up to 14 days prior to the event
• No refunds within 14 days of the event

Online registration:

• Full refund given up to 7 days prior to the event
• No refunds within 7 days of the event

More details to come.

Thank you to all our sponsors.

---